跳至主要内容
临床试验/IRCT20130310012776N7
IRCT20130310012776N7尚未招募3 期

Evaluating the Effect of the Concomitant Administration of Methylphenidate and Amantadine on the TBI-related Outcomes: A Randomized, Double-blind, Placebo-controlled, Parallel trial

Shiraz University of Medical Sciences0 个研究点目标入组 200 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Pure Blunt Traumatic Brain injury
  • The motor component of Glasgow coma score 4 or 5
  • Parenchymal damage less than or equal to 10 cc
  • Heart rate less than 100 beats/min on the recruitment time
  • intensive care unit staying for at least 5 days

排除标准

  • Having Multiple Trauma
  • Penetrating Traumatic Brain Injuries
  • High Cervical Cord Injuries(C1-C4)
  • Need for neurosurgery intervention for any causes
  • Severe Agitation
  • Previous history of Hospital admission due to psychiatric problem
  • Known case of Attention Deficit Hyperactivity Disorder
  • Heart Rate more than120 beats/min without any systemic diseases
  • Active cancer or chemoradiotherapy
  • Ischemic Heart Diseases
  • Glomerular Filtration Rate less than 60 ccs/min
  • Pregnant women
  • Cerebral Palsy
  • Mental Retardation
  • Positive Drug history of Taking Neuroleptics, or Selective Serotonin Reuptake Inhibitors, or Monoamine Oxidase Inhibitor, or Lithium salts, or Propofol, or Thiopental
  • Involved in other clinical trials during the last three months
  • Decline to participate

研究者

相似试验